Stay updated on Quizartinib With Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib With Azacitidine in AML Clinical Trial page.

Latest updates to the Quizartinib With Azacitidine in AML Clinical Trial page
- CheckyesterdayChange DetectedThe history now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAdded Revision: v3.4.2 to the record history and removed the Notice about government funding status (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check36 days agoChange DetectedA government funding/operating-status notice was added to the top of the page, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check43 days agoChange DetectedUI/annotation changes were introduced, including a glossary toggle, color-coded change indicators (green for additions and red for deletions), and an updated revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check57 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) replacing the prior revision (v3.3.3), which affects only revision metadata and does not modify trial data or study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded a new site revision label: Revision: v3.3.3. The HHS Vulnerability Disclosure and the older Revision: v3.3.2 were removed from the page footer.SummaryDifference0.1%

Stay in the know with updates to Quizartinib With Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib With Azacitidine in AML Clinical Trial page.